Daré Bioscience, Inc. (DARE)
NASDAQ: DARE · Real-Time Price · USD
0.7405
-0.0669 (-8.29%)
At close: Sep 24, 2026, 4:00 PM EDT
0.7380
-0.0025 (-0.34%)
Pre-market: Sep 25, 2026, 4:53 AM EDT
Daré Bioscience Employees
As of December 31, 2025, Daré Bioscience had 24 total employees, including 21 full-time and 3 part-time employees. The number of employees increased by 1 or 4.35% compared to the previous year.
Employees
24
Change (1Y)
1
Growth (1Y)
4.35%
Revenue / Employee
$56,914
Profits / Employee
-$457,798
Market Cap
11.32M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 24 | 1 | 4.35% | 21 | 3 |
| Dec 31, 2024 | 23 | -3 | -11.54% | 21 | 2 |
| Dec 31, 2023 | 26 | -4 | -13.33% | 23 | 3 |
| Dec 31, 2022 | 30 | 2 | 7.14% | 25 | 5 |
| Dec 31, 2021 | 28 | 5 | 21.74% | 20 | 8 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Pluri | 113 |
| Jaguar Health | 47 |
| Lisata Therapeutics | 21 |
| NeuroSense Therapeutics | 17 |
| CalciMedica | 15 |
| BioVie | 13 |
| AEON Biopharma | 8 |
| Intensity Therapeutics | 7 |
DARE News
- 1 day ago - Daré Bioscience Proxy statement: Proxy filing - Filings
- 10 days ago - Dare Bioscience publishes results from Sildenafil Cream study - TheFly
- 10 days ago - Daré Bioscience Announces Peer-Reviewed Publication of Phase 1 Sildenafil Cream Study in Men Demonstrating Substantially Lower Systemic Exposure Versus Oral Sildenafil - GlobeNewsWire
- 13 days ago - Daré Bioscience Transcript: H.C. Wainwright 28th Annual Global Investment Conference - Transcripts
- 13 days ago - Daré Bioscience Presentation for H.C. Wainwright 28th Annual Global Investment Conference Now Available On-Demand - GlobeNewsWire
- 15 days ago - Daré Bioscience Slides: Corporate presentation - Filings
- 24 days ago - Dare Bioscience announces new $908,000 NIH funding award to advance DARE-PTB2 - TheFly
- 24 days ago - Daré Bioscience Announces New NIH Funding Award for Approximately $908,000 to Advance DARE-PTB2 for the Prevention of Preterm Birth - GlobeNewsWire